Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Inactive 2'-5'-oligoadenylate synthase 1B ((2-5')oligo(A) synthase 1B) (2-5A synthase 1B) (2'-5'-oligoadenylate synthase-like protein 1)

 OAS1B_MOUSE             Reviewed;         376 AA.
Q60856; A8YPE5; A8YPE7; A8YPE8; A8YPE9; E9QKP6; Q78ZX0; Q8JZN0;
Q8JZN4; Q8VI98;
21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
05-SEP-2012, sequence version 3.
07-JUN-2017, entry version 108.
RecName: Full=Inactive 2'-5'-oligoadenylate synthase 1B;
Short=(2-5')oligo(A) synthase 1B;
Short=2-5A synthase 1B;
AltName: Full=2'-5'-oligoadenylate synthase-like protein 1;
Name=Oas1b; Synonyms=Flv, Oias2;
Mus musculus (Mouse).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Mus; Mus.
NCBI_TaxID=10090;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (TRUNCATED FORM), FUNCTION, TISSUE
SPECIFICITY, VARIANT ALA-65, AND VARIANT GLN-190.
STRAIN=C57BL/6J; TISSUE=Spleen;
PubMed=12396720; DOI=10.1089/10799900260286696;
Kakuta S., Shibata S., Iwakura Y.;
"Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene
family.";
J. Interferon Cytokine Res. 22:981-993(2002).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (LONG AND TRUNCATED FORM), VARIANT ALA-65,
VARIANT GLN-190, VARIANT ARG-266, VARIANT THR-322, VARIANT PRO-336,
AND VARIANT PHE-354.
STRAIN=C3H/He, and C3H/RV;
PubMed=12080145; DOI=10.1073/pnas.142287799;
Perelygin A.A., Scherbik S.V., Zhulin I.B., Stockman B.M., Li Y.,
Brinton M.A.;
"Positional cloning of the murine flavivirus resistance gene.";
Proc. Natl. Acad. Sci. U.S.A. 99:9322-9327(2002).
[3]
NUCLEOTIDE SEQUENCE [MRNA] (LONG AND TRUNCATED FORM), POLYMORPHISM,
VARIANT PHE-45, VARIANT CYS-63, VARIANT ALA-65, VARIANT TYR-83,
VARIANT TYR-103, VARIANT PHE-111, VARIANT GLN-118, VARIANT LEU-176,
VARIANT LEU-183, VARIANT THR-184, VARIANT GLN-190, VARIANT HIS-206,
VARIANT ARG-266, VARIANT PRO-336, VARIANT ALA-347, VARIANT THR-350,
AND VARIANT PHE-354.
STRAIN=BALB/cJ, and MBT/Pas;
PubMed=12186974; DOI=10.1073/pnas.172195399;
Mashimo T., Lucas M., Simon-Chazottes D., Frenkiel M.P.,
Montagutelli X., Ceccaldi P.E., Deubel V., Guenet J.L., Despres P.;
"A nonsense mutation in the gene encoding 2'-5'-oligoadenylate
synthetase/L1 isoform is associated with West Nile virus
susceptibility in laboratory mice.";
Proc. Natl. Acad. Sci. U.S.A. 99:11311-11316(2002).
[4]
NUCLEOTIDE SEQUENCE [MRNA] (LONG FORM), VARIANT SER-36, VARIANT
PHE-45, VARIANT GLN-47, VARIANT GLY-50, VARIANT CYS-63, VARIANT
ALA-65, VARIANT TYR-83, VARIANT ARG-90, VARIANT TYR-103, VARIANT
ILE-105, VARIANT PHE-111, VARIANT GLN-118, VARIANT VAL-151, VARIANT
LEU-176, VARIANT GLU-181, VARIANT LEU-183, VARIANT THR-184, VARIANT
HIS-206, VARIANT ARG-266, VARIANT LEU-277, VARIANT PRO-278, VARIANT
VAL-291, VARIANT VAL-299, VARIANT VAL-305, VARIANT PRO-336, VARIANT
ALA-347, VARIANT THR-350, VARIANT PHE-354, AND VARIANT LEU-368.
STRAIN=BID, DHA, MPR, PWD/Phj, and TEH;
PubMed=18460447; DOI=10.1093/molbev/msn106;
Ferguson W., Dvora S., Gallo J., Orth A., Boissinot S.;
"Long-term balancing selection at the west nile virus resistance gene,
Oas1b, maintains transspecific polymorphisms in the house mouse.";
Mol. Biol. Evol. 25:1609-1618(2008).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT ALA-65, AND
VARIANT GLN-190.
STRAIN=C57BL/6J;
PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
Lindblad-Toh K., Eichler E.E., Ponting C.P.;
"Lineage-specific biology revealed by a finished genome assembly of
the mouse.";
PLoS Biol. 7:E1000112-E1000112(2009).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANT ALA-65, AND
VARIANT GLN-190.
Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [MRNA] OF 58-249, VARIANT ALA-65, AND VARIANT
GLN-190.
PubMed=1709495; DOI=10.1093/nar/19.8.1917;
Rutherford M.N., Kumar A., Nissim A., Chebath J., Williams B.R.G.;
"The murine 2-5A synthetase locus: three distinct transcripts from two
linked genes.";
Nucleic Acids Res. 19:1917-1924(1991).
[8]
FUNCTION.
PubMed=16371364; DOI=10.1074/jbc.M508649200;
Kajaste-Rudnitski A., Mashimo T., Frenkiel M.P., Guenet J.L.,
Lucas M., Despres P.;
"The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West
Nile virus replication inside infected cells.";
J. Biol. Chem. 281:4624-4637(2006).
[9]
REVIEW.
PubMed=17024523; DOI=10.1007/s00239-006-0073-3;
Perelygin A.A., Zharkikh A.A., Scherbik S.V., Brinton M.A.;
"The mammalian 2'-5' oligoadenylate synthetase gene family: evidence
for concerted evolution of paralogous Oas1 genes in Rodentia and
Artiodactyla.";
J. Mol. Evol. 63:562-576(2006).
[10]
SUBCELLULAR LOCATION, AND INTERACTION WITH OSBPL1A AND ABCF3.
PubMed=22623793; DOI=10.1128/JVI.00333-12;
Courtney S.C., Di H., Stockman B.M., Liu H., Scherbik S.V.,
Brinton M.A.;
"Identification of novel host cell binding partners of Oas1b, the
protein conferring resistance to flavivirus-induced disease in mice.";
J. Virol. 86:7953-7963(2012).
[11]
FUNCTION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND INDUCTION.
PubMed=27663720; DOI=10.1016/j.meegid.2016.09.018;
Elkhateeb E., Tag-El-Din-Hassan H.T., Sasaki N., Torigoe D.,
Morimatsu M., Agui T.;
"The role of mouse 2',5'-oligoadenylate synthetase 1 paralogs.";
Infect. Genet. Evol. 45:393-401(2016).
-!- FUNCTION: Does not have 2'-5'-OAS activity, but can bind double-
stranded RNA (PubMed:12396720, PubMed:27663720). The full-length
protein displays antiviral activity against flaviviruses such as
west Nile virus (WNV) via an alternative antiviral pathway
independent of RNase L (PubMed:16371364, PubMed:27663720). The
truncated form of the protein lacks antiviral activity
(PubMed:16371364). {ECO:0000269|PubMed:12396720,
ECO:0000269|PubMed:16371364, ECO:0000269|PubMed:27663720}.
-!- SUBUNIT: Interacts with OSBPL1A and ABCF3.
{ECO:0000269|PubMed:22623793}.
-!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
{ECO:0000305|PubMed:22623793}; Single-pass type IV membrane
protein {ECO:0000305|PubMed:22623793}.
-!- TISSUE SPECIFICITY: Thymus and spleen (PubMed:12396720). Expressed
in testes and kidney (PubMed:27663720).
{ECO:0000269|PubMed:12396720, ECO:0000269|PubMed:27663720}.
-!- DEVELOPMENTAL STAGE: Detected 1 week after birth in developing
skin, testes, ovary, kidney and lung.
{ECO:0000269|PubMed:27663720}.
-!- INDUCTION: By type I interferon (IFN) and viruses. Induced by
polyinosinic:polycytidylic acid (poly I:C) (PubMed:27663720).
{ECO:0000269|PubMed:27663720}.
-!- POLYMORPHISM: A nonsense mutation in exon 4 results in a premature
stop codon leading to a truncated form which determines the
resistant/susceptible phenotype of the mice to flaviviruses. Mice
encoding the full-length protein show a flavivirus resistance
phenotype (Flv(r)), whereas mice encoding a C-terminally truncated
protein show a flavivirus susceptible phenotype (Flv(s)).
{ECO:0000269|PubMed:12186974}.
-!- SIMILARITY: Belongs to the 2-5A synthase family. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=BAB84129.1; Type=Frameshift; Positions=173, 175, 177; Evidence={ECO:0000305};
Sequence=CAA39455.1; Type=Frameshift; Positions=173, 175, 177; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AB067529; BAB84129.1; ALT_FRAME; mRNA.
EMBL; AF328926; AAM47542.1; -; mRNA.
EMBL; AF418004; AAM47544.1; -; mRNA.
EMBL; AF418005; AAM47545.1; -; mRNA.
EMBL; AF481734; AAM49738.1; -; Genomic_DNA.
EMBL; AF466822; AAM97603.1; -; mRNA.
EMBL; AF466823; AAM97604.1; -; mRNA.
EMBL; AM887907; CAP12708.1; -; Genomic_DNA.
EMBL; AM887915; CAP12714.1; -; Genomic_DNA.
EMBL; AM887917; CAP12716.1; -; Genomic_DNA.
EMBL; AM887918; CAP12717.1; -; Genomic_DNA.
EMBL; AM887919; CAP12718.1; -; Genomic_DNA.
EMBL; AC115937; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH466529; EDL19747.1; -; Genomic_DNA.
EMBL; X55982; CAA39455.1; ALT_FRAME; mRNA.
PIR; S15661; S15661.
RefSeq; NP_001077394.1; NM_001083925.1.
UniGene; Mm.233471; -.
ProteinModelPortal; Q60856; -.
SMR; Q60856; -.
STRING; 10090.ENSMUSP00000083564; -.
PaxDb; Q60856; -.
PeptideAtlas; Q60856; -.
PRIDE; Q60856; -.
GeneID; 23961; -.
KEGG; mmu:23961; -.
UCSC; uc008zie.1; mouse.
CTD; 23961; -.
MGI; MGI:97430; Oas1b.
HOGENOM; HOG000022614; -.
HOVERGEN; HBG000994; -.
InParanoid; Q60856; -.
KO; K14216; -.
PRO; PR:Q60856; -.
Proteomes; UP000000589; Unplaced.
CleanEx; MM_OAS1B; -.
GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
GO; GO:0005524; F:ATP binding; IEA:InterPro.
GO; GO:0003725; F:double-stranded RNA binding; IDA:UniProtKB.
GO; GO:0016740; F:transferase activity; IEA:InterPro.
GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
GO; GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB.
GO; GO:0009615; P:response to virus; IDA:UniProtKB.
InterPro; IPR006117; 2-5-oligoadenylate_synth_CS.
InterPro; IPR006116; 2-5-oligoadenylate_synth_N.
InterPro; IPR018952; 2-5-oligoAdlate_synth_1_dom2/C.
InterPro; IPR026774; 2-5A_synthase.
PANTHER; PTHR11258; PTHR11258; 1.
Pfam; PF10421; OAS1_C; 1.
PROSITE; PS00833; 25A_SYNTH_2; 1.
PROSITE; PS50152; 25A_SYNTH_3; 1.
1: Evidence at protein level;
Antiviral defense; Complete proteome; Endoplasmic reticulum; Immunity;
Innate immunity; Membrane; Polymorphism; Reference proteome;
RNA-binding; Transmembrane; Transmembrane helix.
CHAIN 1 376 Inactive 2'-5'-oligoadenylate synthase
1B.
/FTId=PRO_0000160261.
TOPO_DOM 1 351 Cytoplasmic. {ECO:0000255}.
TRANSMEM 352 370 Helical; Anchor for type IV membrane
protein. {ECO:0000255}.
TOPO_DOM 371 376 Extracellular. {ECO:0000255}.
VARIANT 36 36 A -> S (in strain: BID, DHA, MPR).
{ECO:0000269|PubMed:18460447}.
VARIANT 45 45 S -> F (in strain: MBT/Pas, PWD/Phj).
{ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 47 47 R -> Q (in strain: DHA).
{ECO:0000269|PubMed:18460447}.
VARIANT 50 50 V -> G (in strain: DHA).
{ECO:0000269|PubMed:18460447}.
VARIANT 63 63 G -> C (in strain: BID, DHA, MPR, MBT/
Pas, PWD/Phj).
{ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 65 65 T -> A (in strain: BALB/c, BID, C57BL/6J,
C3H/He, MBT/Pas, PWD/Phj).
{ECO:0000269|PubMed:12080145,
ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:12396720,
ECO:0000269|PubMed:1709495,
ECO:0000269|PubMed:18460447,
ECO:0000269|PubMed:19468303,
ECO:0000269|Ref.6}.
VARIANT 83 83 S -> Y (in strain: BID, DHA, MPR, MBT/
Pas, PWD/Phj).
{ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 90 90 Q -> R (in strain: DHA).
{ECO:0000269|PubMed:18460447}.
VARIANT 103 103 C -> Y (in strain: MBT/Pas, PWD/Phj).
{ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 105 105 V -> I (in strain: DHA).
{ECO:0000269|PubMed:18460447}.
VARIANT 111 111 C -> F (in strain: MPR, DHA, MBT/Pas,
PWD/Phj). {ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 118 118 H -> Q (in strain: MPR, MBT/Pas, PWD/
Phj). {ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 151 151 L -> V (in strain: BID, MPR).
{ECO:0000269|PubMed:18460447}.
VARIANT 176 176 P -> L (in strain: MBT/Pas, PWD/Phj).
{ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 181 181 K -> E (in strain: DHA).
{ECO:0000269|PubMed:18460447}.
VARIANT 183 183 S -> L (in strain: BID, MBT/Pas, PWD/
Phj). {ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 184 184 I -> T (in strain: BID, DHA, MBT/Pas,
PWD/Phj). {ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 190 190 R -> Q (in strain: BALB/c, C57BL/6J, C3H/
He). {ECO:0000269|PubMed:12080145,
ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:12396720,
ECO:0000269|PubMed:1709495,
ECO:0000269|PubMed:19468303,
ECO:0000269|Ref.6}.
VARIANT 206 206 R -> H (in strain: MBT/Pas, PWD/Phj).
{ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 253 376 Missing (in the truncated form).
VARIANT 266 266 Q -> R (in strain: BID, C3H/RV, DHA, MPR,
MBT/Pas, PWD/Phj).
{ECO:0000269|PubMed:12080145,
ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 277 277 H -> L (in strain: BID).
{ECO:0000269|PubMed:18460447}.
VARIANT 278 278 Q -> P (in strain: DHA).
{ECO:0000269|PubMed:18460447}.
VARIANT 291 291 D -> V (in strain: DHA).
{ECO:0000269|PubMed:18460447}.
VARIANT 299 299 A -> V (in strain: MPR).
{ECO:0000269|PubMed:18460447}.
VARIANT 305 305 I -> V (in strain: MPR).
{ECO:0000269|PubMed:18460447}.
VARIANT 322 322 A -> T (in strain: C3H/RV).
{ECO:0000269|PubMed:12080145}.
VARIANT 336 336 S -> P (in strain: C3H/RV, DHA, MPR, MBT/
Pas, PWD/Phj).
{ECO:0000269|PubMed:12080145,
ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 347 347 G -> A (in strain: DHA, MBT/Pas, PWD/
Phj). {ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 350 350 M -> T (in strain: BID, DHA, MBT/Pas,
PWD/Phj). {ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 354 354 L -> F (in strain: BID, C3H/RV, DHA, MPR,
MBT/Pas, PWD/Phj).
{ECO:0000269|PubMed:12080145,
ECO:0000269|PubMed:12186974,
ECO:0000269|PubMed:18460447}.
VARIANT 368 368 F -> L (in strain: MPR).
{ECO:0000269|PubMed:18460447}.
CONFLICT 58 60 GVK -> VFQ (in Ref. 7; CAA39455).
{ECO:0000305}.
CONFLICT 234 235 VY -> LD (in Ref. 1; BAB84129 and 7;
CAA39455). {ECO:0000305}.
SEQUENCE 376 AA; 43620 MW; 0733589FC702D4C7 CRC64;
MEQDLRSIPA SKLDKFIENH LPDTSFCADL REVIDALCAL LKDRSFRGPV RRMRASKGVK
GKGTTLKGRS DADLVVFLNN LTSFEDQLNQ QGVLIKEIKK QLCEVQHERR CGVKFEVHSL
RSPNSRALSF KLSAPDLLKE VKFDVLPAYD LLDHLNILKK PNQQFYANLI SGRTPPGKEG
KLSICFMGLR KYFLNCRPTK LKRLIRLVTH WYQLCKEKLG DPLPPQYALE LLTVYAWEYG
SRVTKFNTAQ GFRTVLELVT KYKQLQIYWT VYYDFRHQEV SEYLHQQLKK DRPVILDPAD
PTRNIAGLNP KDWRRLAGEA AAWLQYPCFK YRDGSSVCSW EVPTEVGVPM KYLLCRIFWL
LFWSLFHFIF GKTSSG


Related products :

Catalog number Product name Quantity
EIAAB28570 (2-5')oligo(A) synthase 1B,2-5A synthase 1B,2'-5'-oligoadenylate synthase 1B,2'-5'-oligoadenylate synthase-like protein 1,Mouse,Mus musculus,Oas1b,Oias2
EIAAB28571 (2-5')oligo(A) synthase 2,2-5A synthase 2,2'-5'-oligoadenylate synthase 2,Homo sapiens,Human,OAS2,p69 OAS _ p71 OAS,p69OAS _ p71OAS
E0330m ELISA (2-5')oligo(A) synthase 1A,2-5A synthase 1A,2'-5'-oligoadenylate synthase 1A,Mouse,Mus musculus,Oas1a,Oias1,p42 OAS 96T
U0330m CLIA (2-5')oligo(A) synthase 1A,2-5A synthase 1A,2'-5'-oligoadenylate synthase 1A,Mouse,Mus musculus,Oas1a,Oias1,p42 OAS 96T
E0330m ELISA kit (2-5')oligo(A) synthase 1A,2-5A synthase 1A,2'-5'-oligoadenylate synthase 1A,Mouse,Mus musculus,Oas1a,Oias1,p42 OAS 96T
E0330r ELISA kit (2-5')oligo(A) synthase 1,2-5A synthase 1,2'-5'-oligoadenylate synthase 1,Oas1,Rat,Rattus norvegicus 96T
E0330r ELISA (2-5')oligo(A) synthase 1,2-5A synthase 1,2'-5'-oligoadenylate synthase 1,Oas1,Rat,Rattus norvegicus 96T
U0330r CLIA (2-5')oligo(A) synthase 1,2-5A synthase 1,2'-5'-oligoadenylate synthase 1,Oas1,Rat,Rattus norvegicus 96T
U1715h CLIA (2-5')oligo(A) synthase 3,2-5A synthase 3,2'-5'-oligoadenylate synthase 3,Homo sapiens,Human,OAS3,P_OKcl.4,p100 OAS,p100OAS 96T
E1715h ELISA (2-5')oligo(A) synthase 3,2-5A synthase 3,2'-5'-oligoadenylate synthase 3,Homo sapiens,Human,OAS3,P_OKcl.4,p100 OAS,p100OAS 96T
U0330h CLIA (2-5')oligo(A) synthase 1,2-5A synthase 1,2'-5'-oligoadenylate synthase 1,E18_E16,Homo sapiens,Human,OAS1,OIAS,p46_p42 OAS 96T
E0330h ELISA kit (2-5')oligo(A) synthase 1,2-5A synthase 1,2'-5'-oligoadenylate synthase 1,E18_E16,Homo sapiens,Human,OAS1,OIAS,p46_p42 OAS 96T
E1715h ELISA kit (2-5')oligo(A) synthase 3,2-5A synthase 3,2'-5'-oligoadenylate synthase 3,Homo sapiens,Human,OAS3,P_OKcl.4,p100 OAS,p100OAS 96T
E0330h ELISA (2-5')oligo(A) synthase 1,2-5A synthase 1,2'-5'-oligoadenylate synthase 1,E18_E16,Homo sapiens,Human,OAS1,OIAS,p46_p42 OAS 96T
E0330p ELISA (2-5')oligo(A) synthase 1,2-5A synthase 1,2'-5'-oligoadenylate synthase 1,OAS1,p42 OAS,Pig,Sus scrofa 96T
E0330p ELISA kit (2-5')oligo(A) synthase 1,2-5A synthase 1,2'-5'-oligoadenylate synthase 1,OAS1,p42 OAS,Pig,Sus scrofa 96T
U0330p CLIA (2-5')oligo(A) synthase 1,2-5A synthase 1,2'-5'-oligoadenylate synthase 1,OAS1,p42 OAS,Pig,Sus scrofa 96T
E0167h ELISA Beta-trace protein,Cerebrin-28,Glutathione-independent PGD synthase,Homo sapiens,Human,Lipocalin-type prostaglandin-D synthase,PDS,PGD2 synthase,PGDS,PGDS2,Prostaglandin-D2 synthase,Prostaglandi 96T
E0167h ELISA kit Beta-trace protein,Cerebrin-28,Glutathione-independent PGD synthase,Homo sapiens,Human,Lipocalin-type prostaglandin-D synthase,PDS,PGD2 synthase,PGDS,PGDS2,Prostaglandin-D2 synthase,Prostag 96T
U0167h CLIA Beta-trace protein,Cerebrin-28,Glutathione-independent PGD synthase,Homo sapiens,Human,Lipocalin-type prostaglandin-D synthase,PDS,PGD2 synthase,PGDS,PGDS2,Prostaglandin-D2 synthase,Prostaglandin 96T
EIAAB06601 CDP-DAG synthase 2,CDP-DG synthase 2,CDP-diacylglycerol synthase 2,CDP-diglyceride pyrophosphorylase 2,CDP-diglyceride synthase 2,CDS 2,CDS2,CTP phosphatidate cytidylyltransferase 2,Homo sapiens,Human
EIAAB06599 CDP-DAG synthase 1,CDP-DG synthase 1,CDP-diacylglycerol synthase 1,CDP-diglyceride pyrophosphorylase 1,CDP-diglyceride synthase 1,Cds,CDS 1,Cds1,CTP phosphatidate cytidylyltransferase 1,Mouse,Mus musc
EIAAB06603 CDP-DAG synthase 2,CDP-DG synthase 2,CDP-diacylglycerol synthase 2,CDP-diglyceride pyrophosphorylase 2,CDP-diglyceride synthase 2,CDS 2,Cds2,CTP phosphatidate cytidylyltransferase 2,Mouse,Mus musculus
EIAAB06597 CDP-DAG synthase 1,CDP-DG synthase 1,CDP-diacylglycerol synthase 1,CDP-diglyceride pyrophosphorylase 1,CDP-diglyceride synthase 1,CDS,CDS 1,CDS1,CTP phosphatidate cytidylyltransferase 1,Homo sapiens,H
EIAAB06600 Bos taurus,Bovine,CDP-DAG synthase 2,CDP-DG synthase 2,CDP-diacylglycerol synthase 2,CDP-diglyceride pyrophosphorylase 2,CDP-diglyceride synthase 2,CDS 2,CDS2,CTP phosphatidate cytidylyltransferase 2,


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur